Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/9303
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Author: Branford, S.
Rudzki, Z.
Walsh, S.
Parkinson, I.
Grigg, A.
Szer, J.
Taylor, K.
Hermann, R.
Seymour, J.
Arthur, C.
Joske, D.
Lynch, K.
Hughes, T.
Citation: Blood, 2003; 102(1):276-283
Publisher: American Society of Hematology
Issue Date: 2003
ISSN: 0006-4971
1528-0020
Statement of
Responsibility: 
Susan Branford, Zbigniew Rudzki, Sonya Walsh, Ian Parkinson, Andrew Grigg, Jeff Szer, Kerry Taylor, Richard Herrmann, John F. Seymour, Chris Arthur, David Joske, Kevin Lynch, and Tim Hughes
Abstract: Abstract not available
Keywords: Humans; Disease Progression; Piperazines; Pyrimidines; Fusion Proteins, bcr-abl; Adenosine Triphosphate; Prognosis; Survival Analysis; DNA Mutational Analysis; Binding Sites; Protein Structure, Tertiary; Drug Resistance, Neoplasm; Mutation; Genes, abl; Adult; Aged; Middle Aged; Female; Male; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Rights: © 2003 by The American Society of Hematology
RMID: 0020031201
DOI: 10.1182/blood-2002-09-2896
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.